Anlv Biotechnology
Tesamorelin
Finnrick tested 4 samples of Tesamorelin from Anlv Biotechnology between 31 Aug 2025 and 7 Mar 2026. Test scores average below 4 or some scores below 3, and at least 2 tests, warrant a tentative Finnrick Rating of E (Bad).
Finnrick Rating™
Tentative Rating
Anlv Biotechnology
Tesamorelin
Tested 4 Samples
Last test 7 Mar 2026
Take Action
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Tesamorelin tests from top-rated vendors:
All Tesamorelin tests from Anlv Biotechnology
Samples are tested in commercial labs
Tests Count
4
Scores
AVGMINMAX
Last
7 Mar 2026
First
31 Aug 2025
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 7 Mar 2026 | View | 10mg | 12.5mg | +25.0% | 99.80% | TSM10HN202602 | No Label / Silver Crimp / Clear Blue Cap | Lab G | Public | |
| 20 Feb 2026 | View | 10mg | 11.6mg | +16.0% | 99.88% | (no batch ID) | White Label / Silver Crimp / White Cap | Lab E | Public | |
| 29 Jan 2026 | View | 10mg | 9.84mg | -1.6% | 99.90% | TSM10 | Silver Label / Silver Crimp / Black Cap | Lab E | Public | |
| 31 Aug 2025 | View | 10mg | 3.86mg | -61.4% | 93.96% | (no batch ID) | No Label / Silver Crimp / Blue Cap | Lab E | Public | |